We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gilead Subsidiary Wins Louisiana’s ‘Netflix’ Hep C Contract
Gilead Subsidiary Wins Louisiana’s ‘Netflix’ Hep C Contract
Gilead subsidiary Asegua Therapeutics won the exclusive contract to treat Louisiana’s poor and imprisoned hepatitis C patients, health officials in the Pelican State announced Tuesday.